FRESENIUS MEDICAL CARE-ADR (FMS) Stock News
NYSE:FMS - New York Stock Exchange, Inc. - US3580291066 - ADR - Currency: USD
FMS Latest News, Press Relases and Analysis
Reasons to Add Fresenius Medical Stock to Your Portfolio Now
FMS continues to gain traction on the back of acquisitions & partnerships. A tough regulatory environment raises concerns.
Fresenius (FMS) Upgraded to Buy: Here's Why
Fresenius (FMS) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
Why This 1 Momentum Stock Could Be a Great Addition to Your Portfolio
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
HOLX vs. DGX: Which Women's Health-Focused Stock Is the Better Pick?
The women's health market is booming, with Hologic and Quest Diagnostics leading the charge. But which one stands out more for investors today?
Here's Why Fresenius (FMS) is a Strong Value Stock
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Fresenius (FMS) is a Great Momentum Stock: Should You Buy?
Does Fresenius (FMS) have what it takes to be a top stock pick for momentum investors? Let's find out.
New Strong Buy Stocks for May 9th
CBNA, FMS, BNTGY, WYY and BCRX have been added to the Zacks Rank #1 (Strong Buy) List on May 9, 2025.
Best Value Stocks to Buy for May 9th
BNTGY, SSUMY and FMS made it to the Zacks Rank #1 (Strong Buy) value stocks list on May 9, 2025.
Best Income Stocks to Buy for May 9th
SSUMY and FMS made it to the Zacks Rank #1 (Strong Buy) income stocks list on May 9, 2025.
Fresenius (FMS) is a Top-Ranked Momentum Stock: Should You Buy?
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
5 High-Flying Medical Instrument Stocks to Buy Despite Recent Turmoil
Five high-flying medical instrument stocks are: DXCM, IDXX, NPCE, CLPT, FMS.
FMS Stock Up as Q1 Earnings Beat Estimates, Revenues Up Y/Y
Fresenius Medical's first-quarter results showcase a strong segmental performance, along with reiterating its 2025 outlook for revenue growth.
Why Fresenius (FMS) is a Top Value Stock for the Long-Term
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Watch These 3 MedTech Stocks for Q1 Earnings: Beat or Miss?
MedTech companies' quarterly results are likely to reflect strength in customer demand. Let's see how FMS, MASI and CLOV are placed ahead of their earnings releases.
Here's Why You Should Add Veeva Stock to Your Portfolio Now
VEEV's robust product portfolio and a slew of strategic deals raise optimism about the stock.
Here's Why Fresenius (FMS) is a Strong Value Stock
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Why Fresenius Medical Care Stock Might be a Great Pick
FMS has seen solid earnings estimate revision activity over the past month, and belongs to a strong industry as well.
BAX Stock Gains Following Q1 Earnings Beat Estimates, Revenues Up Y/Y
Baxter reports better-than-expected first-quarter results. However, the company's gross margin contracts. Shares rise in pre-market.
ARAY Stock Down Despite Q3 Earnings Beat Estimates, Revenues Up Y/Y
Accuray reports solid fiscal third-quarter results, witnessing growth in Product & Services revenues and reduced operating expenses.
GKOS Stock Falls Despite Q1 Earnings & Revenue Beat, Margins Decline
Glaukos' first-quarter results showcase a strong uptick in revenues. However, continued operating loss remains a cause of concern.
CAH Q3 Earnings Beat Estimates, '25 EPS View Raised, Stock Gains
Cardinal Health's third-quarter fiscal 2025 results benefit from solid Medical and Other segment revenue growth. However, OptumRx contract expiry hurts Pharmaceutical segment sales.
CNMD Stock Up On Q1 Earnings & Sales Beat, Raised 2025 Outlook
CNMD reports solid first-quarter results, driven by improving sales across both segments.
ECL Stock Up in Pre-Market Following Q1 Earnings Meet Estimates
Ecolab's robust performance across the majority of its segments drives its first-quarter organic sales despite business challenges.
RVTY Rises as Q1 Earnings & Sales Beat Estimates, '25 Sales View Up
Revvity's first-quarter results showcase strong growth in Diagnostics business, along with recovery in Life Sciences segmental sales.
Avantor Stock Declines Despite Q1 Earnings In-Line, Revenues Down Y/Y
AVTR's Bioscience Production segment witnesses robust growth amid macroeconomic pressures.
WST Stock Rises on Q1 Earnings Beat, EPS View Up on Tariff & FX Benefit
West Pharmaceutical's first-quarter top line continues to benefit from revenue growth in its Proprietary Products segment.
ISRG Stock Falls Despite Q1 Earnings Beat, Gross Margin Contracts
ISRG's first-quarter results reflect a healthy demand for procedures on higher system utilization. However, tariffs lead to a decline in the gross margin outlook.
Should Value Investors Buy Fresenius Medical Care AG & Co. (FMS) Stock?
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Is Concentra Group Holdings Parent, Inc. (CON) Outperforming Other Medical Stocks This Year?
Here is how Concentra Group (CON) and Fresenius (FMS) have performed compared to their sector so far this year.
Mentions: CON
Is Fresenius Medical Care (FMS) the Best German Stock to Buy According to Hedge Funds?
We recently published a list of 12 Best German Stocks to Buy According to Hedge Funds. In this article, we are going to take a look at where Fresenius Medical Care (NYSE:FMS) stands against other best German stocks to buy according to hedge funds. Germany’s economy is facing continued weakness. According to a report published […]
Is Fresenius Medical Care AG (FMS) the Most Undervalued Healthcare Stock to Buy According to Analysts?
We recently published a list of 8 Most Undervalued Healthcare Stocks to Buy According to Analysts. In this article, we are going to take a look at where Fresenius Medical Care AG (NYSE:FMS) stands against other most undervalued healthcare stocks to buy according to analysts. Rising Healthcare Costs and the Impact of Tariffs on US-China […]
Zacks.com featured highlights include JD.com, Universal Health Services, Fresenius Medical Care and Qifu Technology
JD.com, Universal Health Services, Fresenius Medical Care and Qifu Technology are part of the Zacks Screen of the Week article.